Dimethoxycurcumin

CAS No. 160096-59-3

Dimethoxycurcumin( Veratrylcurcuminoid )

Catalog No. M27175 CAS No. 160096-59-3

Dimethoxycurcumin is an analog of curcumin with more metabolical stability. Dimethoxycurcumin induces epigenetic changes in leukemia cells and the expression of promoter methylated genes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 44 In Stock
10MG 70 In Stock
25MG 136 In Stock
50MG 233 In Stock
100MG 341 In Stock
200MG 486 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dimethoxycurcumin
  • Note
    Research use only, not for human use.
  • Brief Description
    Dimethoxycurcumin is an analog of curcumin with more metabolical stability. Dimethoxycurcumin induces epigenetic changes in leukemia cells and the expression of promoter methylated genes.
  • Description
    Dimethoxycurcumin is an analog of curcumin with more metabolical stability. Dimethoxycurcumin induces epigenetic changes in leukemia cells and the expression of promoter methylated genes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Veratrylcurcuminoid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Akt1| Akt2| Akt3| PKA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    160096-59-3
  • Formula Weight
    396.439
  • Molecular Formula
    C23H24O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (252.25 mM)
  • SMILES
    COc1ccc(\C=C\C(=O)CC(=O)\C=C\c2ccc(OC)c(OC)c2)cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Blake JF, et al. Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors. J Med Chem. 2012 Sep 27;55(18):8110-27.
molnova catalog
related products
  • Kemptide TFA (65189-...

    Kemptide TFA is a synthetic heptapeptide, acting as a substrate for cAMP-dependent protein kinase (PK).

  • gp38

    gp38

  • (D-2-Nal5,Cys6·11,Ty...

    BIM 23042, a certain somatostatin (SS) octapeptide analogue, is a selective neuropeptide neuromedin B receptor (NMB-R, BB1) antagonist. BIM 23042 has 100-fold lower affinity for gastrin-releasing peptide (GRP) receptor (BB2). BIM 23042 inhibits Neuromedin?B?, ICI 216140 and DPDM-bombesin ethylamide-induced Ca2+ release.